Vir Biotechnology, Inc. (VIR) has 12 identified peers for comparison in the Healthcare sector. Peers include AKRO, AMLX, BPMC, CVAC, DAWN, ICPT and others.
VIR has a market capitalization of $1.61B, compared to an average peer market cap of $5.2B. VIR is notably smaller than its average peer.
